世界のE3ユビキチンタンパク質リガーゼXIAP市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global E3 Ubiquitin Protein Ligase XIAP Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5722
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、E3ユビキチンタンパク質リガーゼXIAPの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ASTX-660、FL-118、AD-O53.2、LCL-161、SM-1200、その他）、用途別市場規模（固形腫瘍、卵管がん、肺がん、腹膜がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・E3ユビキチンタンパク質リガーゼXIAPの市場動向
・企業の競争状況、市場シェア
・E3ユビキチンタンパク質リガーゼXIAPの種類別市場規模と予測2016-2027（ASTX-660、FL-118、AD-O53.2、LCL-161、SM-1200、その他）
・E3ユビキチンタンパク質リガーゼXIAPの用途別市場規模と予測2016-2027（固形腫瘍、卵管がん、肺がん、腹膜がん、その他）
・E3ユビキチンタンパク質リガーゼXIAPの北米市場規模2016-2027（アメリカ、カナダ）
・E3ユビキチンタンパク質リガーゼXIAPの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・E3ユビキチンタンパク質リガーゼXIAPのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・E3ユビキチンタンパク質リガーゼXIAPの中南米市場規模2016-2027（メキシコ、ブラジル）
・E3ユビキチンタンパク質リガーゼXIAPの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Adamed Sp z oo、Astex Pharmaceuticals Inc、Bristol-Myers Squibb Company、F. Hoffmann-La Roche Ltd、Novartis AG、Noxopharm Ltd、Takeda Pharmaceutical Company Ltd）
・結論

Market Analysis and Insights: Global E3 Ubiquitin Protein Ligase XIAP Market
The global E3 Ubiquitin Protein Ligase XIAP market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global E3 Ubiquitin Protein Ligase XIAP market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global E3 Ubiquitin Protein Ligase XIAP market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global E3 Ubiquitin Protein Ligase XIAP market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global E3 Ubiquitin Protein Ligase XIAP market.

Global E3 Ubiquitin Protein Ligase XIAP Scope and Market Size
E3 Ubiquitin Protein Ligase XIAP market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global E3 Ubiquitin Protein Ligase XIAP market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ASTX-660
FL-118
AD-O53.2
LCL-161
SM-1200
Others

Segment by Application
Solid Tumor
Fallopian Tube Cancer
Lung Cancer
Peritoneal Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Adamed Sp z oo
Astex Pharmaceuticals Inc
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd
Novartis AG
Noxopharm Ltd
Takeda Pharmaceutical Company Ltd

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global E3 Ubiquitin Protein Ligase XIAP Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ASTX-660
1.2.3 FL-118
1.2.4 AD-O53.2
1.2.5 LCL-161
1.2.6 SM-1200
1.2.7 Others
1.3 Market by Application
1.3.1 Global E3 Ubiquitin Protein Ligase XIAP Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumor
1.3.3 Fallopian Tube Cancer
1.3.4 Lung Cancer
1.3.5 Peritoneal Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global E3 Ubiquitin Protein Ligase XIAP Market Perspective (2016-2027)
2.2 E3 Ubiquitin Protein Ligase XIAP Growth Trends by Regions
2.2.1 E3 Ubiquitin Protein Ligase XIAP Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 E3 Ubiquitin Protein Ligase XIAP Historic Market Share by Regions (2016-2021)
2.2.3 E3 Ubiquitin Protein Ligase XIAP Forecasted Market Size by Regions (2022-2027)
2.3 E3 Ubiquitin Protein Ligase XIAP Industry Dynamic
2.3.1 E3 Ubiquitin Protein Ligase XIAP Market Trends
2.3.2 E3 Ubiquitin Protein Ligase XIAP Market Drivers
2.3.3 E3 Ubiquitin Protein Ligase XIAP Market Challenges
2.3.4 E3 Ubiquitin Protein Ligase XIAP Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top E3 Ubiquitin Protein Ligase XIAP Players by Revenue
3.1.1 Global Top E3 Ubiquitin Protein Ligase XIAP Players by Revenue (2016-2021)
3.1.2 Global E3 Ubiquitin Protein Ligase XIAP Revenue Market Share by Players (2016-2021)
3.2 Global E3 Ubiquitin Protein Ligase XIAP Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by E3 Ubiquitin Protein Ligase XIAP Revenue
3.4 Global E3 Ubiquitin Protein Ligase XIAP Market Concentration Ratio
3.4.1 Global E3 Ubiquitin Protein Ligase XIAP Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by E3 Ubiquitin Protein Ligase XIAP Revenue in 2020
3.5 E3 Ubiquitin Protein Ligase XIAP Key Players Head office and Area Served
3.6 Key Players E3 Ubiquitin Protein Ligase XIAP Product Solution and Service
3.7 Date of Enter into E3 Ubiquitin Protein Ligase XIAP Market
3.8 Mergers & Acquisitions, Expansion Plans

4 E3 Ubiquitin Protein Ligase XIAP Breakdown Data by Type
4.1 Global E3 Ubiquitin Protein Ligase XIAP Historic Market Size by Type (2016-2021)
4.2 Global E3 Ubiquitin Protein Ligase XIAP Forecasted Market Size by Type (2022-2027)

5 E3 Ubiquitin Protein Ligase XIAP Breakdown Data by Application
5.1 Global E3 Ubiquitin Protein Ligase XIAP Historic Market Size by Application (2016-2021)
5.2 Global E3 Ubiquitin Protein Ligase XIAP Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America E3 Ubiquitin Protein Ligase XIAP Market Size (2016-2027)
6.2 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Type
6.2.1 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021)
6.2.2 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027)
6.2.3 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2027)
6.3 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Application
6.3.1 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021)
6.3.2 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027)
6.3.3 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2027)
6.4 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Country
6.4.1 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2016-2021)
6.4.2 North America E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe E3 Ubiquitin Protein Ligase XIAP Market Size (2016-2027)
7.2 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Type
7.2.1 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021)
7.2.2 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027)
7.2.3 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2027)
7.3 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Application
7.3.1 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021)
7.3.2 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027)
7.3.3 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2027)
7.4 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Country
7.4.1 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2016-2021)
7.4.2 Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size (2016-2027)
8.2 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Type
8.2.1 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021)
8.2.2 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027)
8.2.3 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2027)
8.3 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Application
8.3.1 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021)
8.3.2 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027)
8.3.3 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2027)
8.4 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Region
8.4.1 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Region (2016-2021)
8.4.2 Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size (2016-2027)
9.2 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Type
9.2.1 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021)
9.2.2 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027)
9.2.3 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2027)
9.3 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Application
9.3.1 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021)
9.3.2 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027)
9.3.3 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2027)
9.4 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Country
9.4.1 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2016-2021)
9.4.2 Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size (2016-2027)
10.2 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Type
10.2.1 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021)
10.2.2 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027)
10.2.3 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2027)
10.3 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Application
10.3.1 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021)
10.3.2 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027)
10.3.3 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2027)
10.4 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Country
10.4.1 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2016-2021)
10.4.2 Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Adamed Sp z oo
11.1.1 Adamed Sp z oo Company Details
11.1.2 Adamed Sp z oo Business Overview
11.1.3 Adamed Sp z oo E3 Ubiquitin Protein Ligase XIAP Introduction
11.1.4 Adamed Sp z oo Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
11.1.5 Adamed Sp z oo Recent Development
11.2 Astex Pharmaceuticals Inc
11.2.1 Astex Pharmaceuticals Inc Company Details
11.2.2 Astex Pharmaceuticals Inc Business Overview
11.2.3 Astex Pharmaceuticals Inc E3 Ubiquitin Protein Ligase XIAP Introduction
11.2.4 Astex Pharmaceuticals Inc Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
11.2.5 Astex Pharmaceuticals Inc Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company E3 Ubiquitin Protein Ligase XIAP Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Details
11.4.2 F. Hoffmann-La Roche Ltd Business Overview
11.4.3 F. Hoffmann-La Roche Ltd E3 Ubiquitin Protein Ligase XIAP Introduction
11.4.4 F. Hoffmann-La Roche Ltd Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Ltd Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG E3 Ubiquitin Protein Ligase XIAP Introduction
11.5.4 Novartis AG Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Noxopharm Ltd
11.6.1 Noxopharm Ltd Company Details
11.6.2 Noxopharm Ltd Business Overview
11.6.3 Noxopharm Ltd E3 Ubiquitin Protein Ligase XIAP Introduction
11.6.4 Noxopharm Ltd Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
11.6.5 Noxopharm Ltd Recent Development
11.7 Takeda Pharmaceutical Company Ltd
11.7.1 Takeda Pharmaceutical Company Ltd Company Details
11.7.2 Takeda Pharmaceutical Company Ltd Business Overview
11.7.3 Takeda Pharmaceutical Company Ltd E3 Ubiquitin Protein Ligase XIAP Introduction
11.7.4 Takeda Pharmaceutical Company Ltd Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
11.7.5 Takeda Pharmaceutical Company Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global E3 Ubiquitin Protein Ligase XIAP Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ASTX-660
Table 3. Key Players of FL-118
Table 4. Key Players of AD-O53.2
Table 5. Key Players of LCL-161
Table 6. Key Players of SM-1200
Table 7. Key Players of Others
Table 8. Global E3 Ubiquitin Protein Ligase XIAP Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global E3 Ubiquitin Protein Ligase XIAP Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global E3 Ubiquitin Protein Ligase XIAP Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global E3 Ubiquitin Protein Ligase XIAP Market Share by Regions (2016-2021)
Table 12. Global E3 Ubiquitin Protein Ligase XIAP Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global E3 Ubiquitin Protein Ligase XIAP Market Share by Regions (2022-2027)
Table 14. E3 Ubiquitin Protein Ligase XIAP Market Trends
Table 15. E3 Ubiquitin Protein Ligase XIAP Market Drivers
Table 16. E3 Ubiquitin Protein Ligase XIAP Market Challenges
Table 17. E3 Ubiquitin Protein Ligase XIAP Market Restraints
Table 18. Global E3 Ubiquitin Protein Ligase XIAP Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global E3 Ubiquitin Protein Ligase XIAP Market Share by Players (2016-2021)
Table 20. Global Top E3 Ubiquitin Protein Ligase XIAP Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in E3 Ubiquitin Protein Ligase XIAP as of 2020)
Table 21. Ranking of Global Top E3 Ubiquitin Protein Ligase XIAP Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by E3 Ubiquitin Protein Ligase XIAP Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players E3 Ubiquitin Protein Ligase XIAP Product Solution and Service
Table 25. Date of Enter into E3 Ubiquitin Protein Ligase XIAP Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021) (US$ Million)
Table 28. Global E3 Ubiquitin Protein Ligase XIAP Revenue Market Share by Type (2016-2021)
Table 29. Global E3 Ubiquitin Protein Ligase XIAP Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global E3 Ubiquitin Protein Ligase XIAP Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global E3 Ubiquitin Protein Ligase XIAP Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global E3 Ubiquitin Protein Ligase XIAP Revenue Market Share by Application (2016-2021)
Table 33. Global E3 Ubiquitin Protein Ligase XIAP Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global E3 Ubiquitin Protein Ligase XIAP Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021) (US$ Million)
Table 36. North America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021) (US$ Million)
Table 38. North America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size by Country (2022-2027) & (US$ Million)
Table 65. Adamed Sp z oo Company Details
Table 66. Adamed Sp z oo Business Overview
Table 67. Adamed Sp z oo E3 Ubiquitin Protein Ligase XIAP Product
Table 68. Adamed Sp z oo Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021) & (US$ Million)
Table 69. Adamed Sp z oo Recent Development
Table 70. Astex Pharmaceuticals Inc Company Details
Table 71. Astex Pharmaceuticals Inc Business Overview
Table 72. Astex Pharmaceuticals Inc E3 Ubiquitin Protein Ligase XIAP Product
Table 73. Astex Pharmaceuticals Inc Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021) & (US$ Million)
Table 74. Astex Pharmaceuticals Inc Recent Development
Table 75. Bristol-Myers Squibb Company Company Details
Table 76. Bristol-Myers Squibb Company Business Overview
Table 77. Bristol-Myers Squibb Company E3 Ubiquitin Protein Ligase XIAP Product
Table 78. Bristol-Myers Squibb Company Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021) & (US$ Million)
Table 79. Bristol-Myers Squibb Company Recent Development
Table 80. F. Hoffmann-La Roche Ltd Company Details
Table 81. F. Hoffmann-La Roche Ltd Business Overview
Table 82. F. Hoffmann-La Roche Ltd E3 Ubiquitin Protein Ligase XIAP Product
Table 83. F. Hoffmann-La Roche Ltd Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021) & (US$ Million)
Table 84. F. Hoffmann-La Roche Ltd Recent Development
Table 85. Novartis AG Company Details
Table 86. Novartis AG Business Overview
Table 87. Novartis AG E3 Ubiquitin Protein Ligase XIAP Product
Table 88. Novartis AG Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021) & (US$ Million)
Table 89. Novartis AG Recent Development
Table 90. Noxopharm Ltd Company Details
Table 91. Noxopharm Ltd Business Overview
Table 92. Noxopharm Ltd E3 Ubiquitin Protein Ligase XIAP Product
Table 93. Noxopharm Ltd Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021) & (US$ Million)
Table 94. Noxopharm Ltd Recent Development
Table 95. Takeda Pharmaceutical Company Ltd Company Details
Table 96. Takeda Pharmaceutical Company Ltd Business Overview
Table 97. Takeda Pharmaceutical Company Ltd E3 Ubiquitin Protein Ligase XIAP Product
Table 98. Takeda Pharmaceutical Company Ltd Revenue in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021) & (US$ Million)
Table 99. Takeda Pharmaceutical Company Ltd Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global E3 Ubiquitin Protein Ligase XIAP Market Share by Type: 2020 VS 2027
Figure 2. ASTX-660 Features
Figure 3. FL-118 Features
Figure 4. AD-O53.2 Features
Figure 5. LCL-161 Features
Figure 6. SM-1200 Features
Figure 7. Others Features
Figure 8. Global E3 Ubiquitin Protein Ligase XIAP Market Share by Application: 2020 VS 2027
Figure 9. Solid Tumor Case Studies
Figure 10. Fallopian Tube Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Peritoneal Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. E3 Ubiquitin Protein Ligase XIAP Report Years Considered
Figure 15. Global E3 Ubiquitin Protein Ligase XIAP Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global E3 Ubiquitin Protein Ligase XIAP Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global E3 Ubiquitin Protein Ligase XIAP Market Share by Regions: 2020 VS 2027
Figure 18. Global E3 Ubiquitin Protein Ligase XIAP Market Share by Regions (2022-2027)
Figure 19. Global E3 Ubiquitin Protein Ligase XIAP Market Share by Players in 2020
Figure 20. Global Top E3 Ubiquitin Protein Ligase XIAP Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in E3 Ubiquitin Protein Ligase XIAP as of 2020
Figure 21. The Top 10 and 5 Players Market Share by E3 Ubiquitin Protein Ligase XIAP Revenue in 2020
Figure 22. Global E3 Ubiquitin Protein Ligase XIAP Revenue Market Share by Type (2016-2021)
Figure 23. Global E3 Ubiquitin Protein Ligase XIAP Revenue Market Share by Type (2022-2027)
Figure 24. North America E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America E3 Ubiquitin Protein Ligase XIAP Market Share by Type (2016-2027)
Figure 26. North America E3 Ubiquitin Protein Ligase XIAP Market Share by Application (2016-2027)
Figure 27. North America E3 Ubiquitin Protein Ligase XIAP Market Share by Country (2016-2027)
Figure 28. United States E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe E3 Ubiquitin Protein Ligase XIAP Market Share by Type (2016-2027)
Figure 32. Europe E3 Ubiquitin Protein Ligase XIAP Market Share by Application (2016-2027)
Figure 33. Europe E3 Ubiquitin Protein Ligase XIAP Market Share by Country (2016-2027)
Figure 34. Germany E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Share by Type (2016-2027)
Figure 42. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Share by Application (2016-2027)
Figure 43. Asia-Pacific E3 Ubiquitin Protein Ligase XIAP Market Share by Region (2016-2027)
Figure 44. China E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America E3 Ubiquitin Protein Ligase XIAP Market Share by Type (2016-2027)
Figure 52. Latin America E3 Ubiquitin Protein Ligase XIAP Market Share by Application (2016-2027)
Figure 53. Latin America E3 Ubiquitin Protein Ligase XIAP Market Share by Country (2016-2027)
Figure 54. Mexico E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Share by Type (2016-2027)
Figure 58. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Share by Application (2016-2027)
Figure 59. Middle East & Africa E3 Ubiquitin Protein Ligase XIAP Market Share by Country (2016-2027)
Figure 60. Turkey E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE E3 Ubiquitin Protein Ligase XIAP Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Adamed Sp z oo Revenue Growth Rate in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
Figure 64. Astex Pharmaceuticals Inc Revenue Growth Rate in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
Figure 66. F. Hoffmann-La Roche Ltd Revenue Growth Rate in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
Figure 67. Novartis AG Revenue Growth Rate in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
Figure 68. Noxopharm Ltd Revenue Growth Rate in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
Figure 69. Takeda Pharmaceutical Company Ltd Revenue Growth Rate in E3 Ubiquitin Protein Ligase XIAP Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界のDNAリガーゼ市場規模・現状・予測（2021年-2027年）

Global DNA Ligase Market Size, Status and Forecast 2021-2027
QFJ1-4146 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、DNAリガーゼの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バクテリア、ウイルス、動物、植物、その他）、用途別市場規模（クローン、変異検出、次世代シーケンシング、創薬ターゲット）、主要地域別市場規模...

世界のタンパク質グルタミンガンマグルタミルトランスフェラーゼ2市場規模・現状・予測（2021年-2027年）

Global Protein Glutamine Gamma Glutamyltransferase 2 Market Size, Status and Forecast 2021-2027
QFJ1-5969 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、タンパク質グルタミンガンマグルタミルトランスフェラーゼ2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAT-5571、ERW-1041E、ZED-1227、その他）、用途別市場規模（病院、クリニッ...

世界のプロテインキナーゼCイプシロン型市場規模・現状・予測（2021年-2027年）

Global Protein Kinase C Epsilon Type Market Size, Status and Forecast 2021-2027
QFJ1-5970 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、プロテインキナーゼCイプシロン型の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブリオスタチン-1、DHACP-6、VMD-1201、その他）、用途別市場規模（アルコール依存症、頭頸部がん、虚血性脳卒...

世界の非構造タンパク質4B市場規模・現状・予測（2021年-2027年）

Global Nonstructural Protein 4B Market Size, Status and Forecast 2021-2027
QFJ1-5896 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、非構造タンパク質4Bの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（INO-8000、GSK-8853、PTC-725、RL-15A、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市...

世界のキネシン様タンパク質KIF11市場規模・現状・予測（2021年-2027年）

Global Kinesin Like Protein KIF11 Market Size, Status and Forecast 2021-2027
QFJ1-5822 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、キネシン様タンパク質KIF11の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（4SC-205、ALN-VSP、BIND-267、BQS-481、その他）、用途別市場規模（結腸直腸がん、乳がん、腎臓がん...

世界のタンパク質産生市場規模・現状・予測（2021年-2027年）

Global Protein Production Market Size, Status and Forecast 2021-2027
QFJ1-4777 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、タンパク質産生の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（原核生物発現システム、哺乳類細胞発現システム、酵母細胞発現システム、その他）、用途別市場規模（商業、学術研究）、主要地域別市場規模（北米、...

世界の無細胞タンパク質合成市場規模・現状・予測（2021年-2027年）

Global Cell-free Protein Synthesis Market Size, Status and Forecast 2021-2027
QFJ1-3993 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、無細胞タンパク質合成の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（大腸菌無細胞タンパク質合成、ウサギ網状赤血球無細胞タンパク質合成、小麦胚芽無細胞タンパク質合成、昆虫細胞無細胞タンパク質合成、哺乳類...

世界のチロシンプロテインキナーゼ受容体TYRO3市場規模・現状・予測（2021年-2027年）

Global Tyrosine Protein Kinase Receptor TYRO3 Market Size, Status and Forecast 2021-2027
QFJ1-6057 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、チロシンプロテインキナーゼ受容体TYRO3の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RXDX-106、ELB-031、Q-701、その他）、用途別市場規模（膀胱がん、乳がん、転移性大腸がん、卵巣...

世界のタンパク質送達市場規模・現状・予測（2021年-2027年）

Global Protein Delivery Market Size, Status and Forecast 2021-2027
QFJ1-5320 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、タンパク質送達の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、インスリン、融合タンパク質、エリスロポエチン、インターフェロン、その他）、用途別市場規模（代謝性疾患、免疫障害、造血系...

世界の輸送タンパク質アッセイキット市場規模・現状・予測（2021年-2027年）

Global Transport Protein Assays Kit Market Size, Status and Forecast 2021-2027
QFJ1-4977 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、輸送タンパク質アッセイキットの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ドラッグデリバリー、医薬品開発、疾患診断）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、...

世界の卵管がん治療薬市場規模・現状・予測（2021年-2027年） Fallopian tube cancer also called as tubal cancer is caused due to uncontrolled growth of cells in fallopian tubes that connect the ovaries and the uterus. Market Analysis and Insights: Global Fallopian Tube Cancer Therapeutics Market The global Fallopian Tube Cancer Therapeutics market size is pro…
世界の固形腫瘍がん治療市場規模・現状・予測（2021年-2027年） An abnormal mass of tissue that usually does not contain cysts or liquid areas. Market Analysis and Insights: Global Solid Tumor Cancer Treatment Market The global Solid Tumor Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% dur…
卵管癌治療薬のグローバル市場：規模・現状・予測2019-2025 Fallopian tube cancer (PFTC), often just tubal cancer, is a malignant neoplasm that originates from the fallopian tube.At present, the global fallopian tube cancer therapeutics market lacks advanced diagnostic methods and highly effective drug delivery systems. Most of the approved drugs are small m…
卵管癌治療薬のグローバル市場：規模・現状・予測2019-2025 Fallopian tube cancer (PFTC), often just tubal cancer, is a malignant neoplasm that originates from the fallopian tube.At present, the global fallopian tube cancer therapeutics market lacks advanced diagnostic methods and highly effective drug delivery systems. Most of the approved drugs are small m…
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…